PSID PositiveID Corporation™ ✈ Revenues Reported!

Subject: PSID PositiveID Corporation™ ✈ Revenues Reported!

View this email online if it doesn’t display correctly
PositiveID Corporation
 (Ticker: PSID)

PositiveID Corporation Reports Revenue From Continuing Operations for First Time in Its History

America’s Front Line Home Defense

PositiveID Corporation™ is an emerging growth company and developer of biological detection systems for America’s homeland defense industry

PositiveID is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats at high-value locations, as well as analyze samples in a medical environment.

Biological Detection and Diagnostics

PositiveID is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats for homeland defense, as well as analyze biological samples at the point of care.
About M-BAND

  “M-BAND continuously and autonomously analyzes air samples for the detection of biological airborne threats in the form of bacteria, viruses, and toxins.”

 The technology was developed under contract with the U.S. Department of Homeland Security (“DHS”) Science & Technology directorate, which included $30 million of contract funding, to detect an attack with a biological weapon.

“PositiveID will feature its handheld Firefly Dx system for point-of-need medical diagnostics and bio-threat detection. The Firefly Dx is designed to meet multiple military health needs with the capability to detect harmful pathogens within minutes”
About Firefly

“PositiveID’s Firefly Dx is a point-of-need, handheld system designed to deliver molecular diagnostic results from a sample in less than 20 minutes”

Diagnostics at the point of need, compared to two to four hours for a lab device, using real-time TaqMan(R) PCR (polymerase chain reaction) chemistry. Firefly is being developed to meet the growing need for more rapid and accurate point-of-need diagnostics that will enable hospitals, first responders, and other providers to save lives.

“The Company is Generating Revenue for the first time since its formation, and we have issued Revenue Guidance through the end of 2015 of $4-10 million (2014 and 2015 combined), $3.3 million of which is currently in backlog.”
PositiveID Corporation Reports Revenue From Continuing Operations for First Time in Its History

Company Also Reports Its Smallest Operating Loss From Continuing Operations Ever

Aug. 15, 2014 (GLOBE NEWSWIRE)

PositiveID Corporation (PSID), a developer of biological detection and diagnostics solutions, today announced it has reported revenue and its smallest operating loss from continuing operations for the first time in the Company’s history. The Company’s Form 10-Q for the quarter ended June 30, 2014, can be found at:

First Half of 2014 Highlights
  • PositiveID issued its first-ever revenue guidance of 4-10 million over 2014 and 2015 (combined), and recognized revenue of 420,000 in the second quarter.
  • PositiveID has reiterated its revenue guidance and currently has booked revenue (revenue recognized plus signed backlog) of 3.5 million.
  • The Company signed a revenue-generating contract with a large government contractor to support a contract for the U.S. Department of Defense (“DoD”) to support the Joint United States Forces Korea Portal and Integrated Threat Recognition (“JUPITR”) Program, and received a follow-on purchase order.
  • A PositiveID teaming partner was awarded a prime contract, with a total value of up to 4 billion for all awardees if all options are exercised, by the U.S. Defense Threat Reduction Agency to conduct research and development to combat weapons of mass destruction.
  • PositiveID signed a Space Act Agreement with NASA’s Ames Research Center wherein NASA will assess the Company’s Firefly technology for potential ground and space applications, while PositiveID will assess the technology to improve its hardware development for extreme environments, such as DoD field applications.
  • The Company strengthened its management team this year with the appointment of Lyle L. Probst as the Company’s president, and the addition of U.S. homeland security and counter-terrorism expert Thomas DiNanno and businessman Michael Campbell to its advisory board.
“I am very proud that we have delivered on the promise we made to investors in early 2014 to enter into agreements related to our M-BAND and Firefly Dx bio-threat detection products with one or more large government and commercial partners in the first half the year,” said William J. Caragol, PositiveID’s Chairman and CEO. “It is clear that the steps we have taken to properly position the Company and our superior technology, both by aligning ourselves with strong partners and pursuing large market opportunities, are bearing fruit. As evidenced by our revenue guidance, we believe this is just the beginning of many accomplishments to come.”
“As more attention is being
paid to the serious need for bio-threat detection
technologies  and programs, we continue to pursue opportunities with the U.S. government and other organizations to employ the critically important capabilities of our M-BAND and Firefly systems, which, we believe, offer accurate biological detection more rapidly than existing systems”
William J. Caragol~CEO    , Inc. announced today that a new audio interview with PositiveID Corporation (“PositiveID” or the “Company”) (PSID), a developer of biological detection and diagnostics solutions, is now available.

The interview can be heard at:

A Large Multi-Million Dollar
Military Contract For the Firefly to detect Ebola Would have a Huge Permanent Impact on the Share Price.
“We are proud of the goals we have achieved
especially our intermediate goal of revenue generation.
We look forward to building on our recent success and continuing to grow our revenue backlog.”
PositiveID Corporation / (Ticker: PSID)

Visit the company website at:

To Subscribe to our
Please read our disclaimer at:

Disclaimer – Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment adviser or licensed stockbroker before investing. You should not invest or trade in any penny stock unless are you are fully prepared, willing, able and expect to lose a hundred pct of your funds,including any profiled company or other company in any other manner mentioned or alluded to by as defined in any medium whatsoever. Compensation: One thousand dollars for a one day awareness on PSID from a third party.The service is provided as a guide to some available investments only, which must be tempered by the investment experience and independent decision making process of the subscriber. The accuracy of issuer documents and information that is submitted to and, its affiliated members and its management for inclusion on this site is principally the responsibility of the particular issuer and its management, its affiliated members and its management is neither responsible for, nor undertakes any steps to check, the accuracy of any information provided by featured companies to potential investors. You should confirm to your own satisfaction the veracity of any information prior to entering into any investment.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s